Two more top FDA of­fi­cials hit the ex­its as an ex­o­dus of se­nior reg­u­la­tors con­tin­ues

To­day will be the last day on the job for two key FDA of­fi­cials, mark­ing the lat­est de­par­tures in a re­cent ex­o­dus of se­nior reg­u­la­tors from the agency.

A spokesper­son for the agency con­firmed that Cur­tis Rose­braugh, the di­rec­tor of the Of­fice of Drug Eval­u­a­tion II, and Don­na Griebel, who’s head­ed the Di­vi­sion of Gas­troen­terol­o­gy and In­born Er­rors Prod­ucts, are both re­tir­ing April 28. They were both part of the Of­fice of New Drugs, un­der the con­trol of Janet Wood­cock since Jan­u­ary, 2017, when John Jenk­ins left af­ter de­lay­ing his de­par­ture in an at­tempt to keep her out.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.